Response to 'Pervasive Sequence Patents Cover the Entire Human Genome'
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Shine Tu, et al., Response to 'Pervasive Sequence Patents Cover the Entire Human Genome', 6 Genome Med. 14 (2014).
Institutional Repository Citation
Shine Tu & Yaniv Heled,
Response to 'Pervasive Sequence Patents Cover the Entire Human Genome',
Faculty Publications By Year